# Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD

> **NCT03216356** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Boston University Charles River Campus**

## Conditions studied

- PTSD

## Interventions

- **BEHAVIORAL:** CBT + ImRs
- **BEHAVIORAL:** CBT + I.E.
- **DRUG:** D-Cycloserine
- **DRUG:** Placebo
- **DRUG:** Study Pill

## Key facts

- **NCT ID:** NCT03216356
- **Lead sponsor:** Boston University Charles River Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-09
- **Primary completion:** 2023-12
- **Final completion:** 2024-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2023-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216356, "Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03216356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*